Shares of Arena Pharmaceuticals rose 3.58% to $69.14 at 12:05 EST on Tuesday, following yesterday’s downward trend. The Nasdaq Stock Market is dropping 0.1% to $12,507.00, after three consecutive sessions in a row of gains, on what at the moment seems, a somewhat negative trend trading session today.

Arena Pharmaceuticals’s last close was $66.75, 30.45% below its 52-week high of $90.19.

Arena Pharmaceuticals’s Sales

Arena Pharmaceuticals’s sales growth is a negative 81.3% for the ongoing quarter and 155.7% for the next. The company’s growth estimates for the ongoing quarter is a negative 4.5% and positive 4.5% for the next.

Arena Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.

Arena Pharmaceuticals’s Stock Top and Bottom Yearly Value

Arena Pharmaceuticals’s stock is valued at $69.14 at 12:05 EST, way below its 52-week high of $90.19 and way above its 52-week low of $32.95.

Arena Pharmaceuticals’s Moving Average

Arena Pharmaceuticals’s worth is below its 50-day moving average of $73.92 and above its 200-day moving average of $68.94.


Please enter your comment!
Please enter your name here